CLINICAL RESEARCH: DIABETES AND OBESITY
Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus
Pilar Herrero, MS*,
Linda R. Peterson, MD , ,
Janet B. McGill, MD ,
Stanley Matthew, MD ,
Donna Lesniak, RN*,
Carmen Dence, MS* and
Robert J. Gropler, MD*, ,*
* Division of Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri
Division of Geriatrics and Nutritional Sciences, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Division of Endocrinology and Metabolism, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Manuscript received January 11, 2005;
revised manuscript received August 15, 2005,
accepted September 12, 2005.
* Reprint requests and correspondence: Dr. Robert J. Gropler, Cardiovascular Imaging Laboratory, Mallinckrodt Institute of Radiology, 510 South Kingshighway, St. Louis, Missouri 63110 (Email: Groplerr{at}mir.wustl.edu).
OBJECTIVES: The purpose of this study was to determine if myocardial fatty acid utilization (MFAU) and myocardial fatty acid oxidation (MFAO) are increased in diabetic patients.
BACKGROUND: Experimental models of diabetes mellitus demonstrate that MFAU and MFAO are increased, and that this dependence on myocardial fatty acid metabolism may be detrimental to cardiac function. Whether similar metabolic changes occur in humans with diabetes mellitus is unclear.
METHODS: Eleven healthy non-diabetic control patients (5 women, ages 25 ± 5 years) and 11 otherwise healthy patients with type 1 diabetes mellitus (T1DM) (8 women, ages 36 ± 10 years, HbA1c 8.4 ± 1.9%) underwent positron emission tomography for the determination of myocardial blood flow (MBF); myocardial oxygen consumption (MVO2); myocardial glucose utilization (MGU); and MFAU, MFAO, and %MFAO.
RESULTS: Plasma lactate, insulin, and MBF levels were similar between the two groups. However, plasma glucose (5.71 ± 0.98 µmol/ml vs. 5.28 ± 0.65 µmol/ml, p = 0.04), free fatty acid levels (0.60 ± 0.24 µmol/ml vs. 0.19 ± 0.07 µmol/ml, p < 0.0001), and MVO2 (6.64 ± 2.21 vs. 4.51 ± 1.39 µmol/g/min, p = 0.007) levels were higher in the T1DM subjects. Furthermore, compared with control patients, T1DM subjects exhibited higher MFAU (213 ± 135 nmol/g/min vs. 57 ± 28 nmol/g/min, p = 0.0004), MFAO (206 ± 131 nmol/g/min s. 50 ± 26 nmol/g/min, p = 0.0002), and %MFAO (94 ± 6% vs. 81 ± 19%, respectively, p = 0.04). In contrast, MGU was lower in T1DM subjects than in controls (207 ± 108 nmol/g/min vs. 403 ± 191 nmol/g/min, p = 0.0008).
CONCLUSIONS: Humans with diabetes mellitus exhibit increased MFAU and MFAO and reduced MGU consistent with observations obtained in experimental models of diabetes.
|
Abbreviations and Acronyms
| | FFA = free fatty acid | | MBF = myocardial blood flow (ml/g/min) | | MFAEF = myocardial fatty acid extraction fraction | | MFAO = myocardial fatty acid oxidation (nmol/g/min) | | MFAU = myocardial fatty acid utilization (nmol/g/min) | | MGEF = myocardial glucose extraction fraction | | MGU = myocardial glucose utilization (nmol/g/min) | | MVO2 = myocardial oxygen consumption (µmol/g/min) | | PET = positron emission tomography | | PPAR = peroxisome proliferator-activated receptor | | T1DM/T2DM = type 1 diabetes mellitus/type 2 diabetes mellitus |
|
This article has been cited by other articles:

|
 |

|
 |
 
K. Singh, T. Singh, and P. L. Sharma
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy
Therapeutic Advances in Cardiovascular Disease,
June 1, 2011;
5(3):
159 - 167.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rijzewijk, R. W. van der Meer, M. Lubberink, H. J. Lamb, J. A. Romijn, A. de Roos, J. W. Twisk, R. J. Heine, A. A. Lammertsma, J. W. A. Smit, et al.
Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism
Diabetes,
November 1, 2010;
59(11):
2747 - 2754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rijzewijk, J. T. Jonker, R. W. van der Meer, M. Lubberink, H. W. de Jong, J. A. Romijn, J. J. Bax, A. de Roos, R. J. Heine, J. W. Twisk, et al.
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
J. Am. Coll. Cardiol.,
July 13, 2010;
56(3):
225 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Brindley, B. P. C. Kok, P. C. Kienesberger, R. Lehner, and J. R. B. Dyck
Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization
Am J Physiol Endocrinol Metab,
May 1, 2010;
298(5):
E897 - E908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taegtmeyer
Tracing Cardiac Metabolism In Vivo: One Substrate at a Time
J. Nucl. Med.,
May 1, 2010;
51(Supplement_1):
80S - 87S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Shivu, T.T. Phan, K. Abozguia, I. Ahmed, A. Wagenmakers, A. Henning, P. Narendran, M. Stevens, and M. Frenneaux
Relationship Between Coronary Microvascular Dysfunction and Cardiac Energetics Impairment in Type 1 Diabetes Mellitus
Circulation,
March 16, 2010;
121(10):
1209 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Peterson and R. J. Gropler
Radionuclide Imaging of Myocardial Metabolism
Circ Cardiovasc Imaging,
March 1, 2010;
3(2):
211 - 222.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley
Myocardial Fatty Acid Metabolism in Health and Disease
Physiol Rev,
January 1, 2010;
90(1):
207 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Anderson, A. P. Kypson, E. Rodriguez, C. A. Anderson, E. J. Lehr, and P. D. Neufer
Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart
J. Am. Coll. Cardiol.,
November 10, 2009;
54(20):
1891 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Rijzewijk, R. W. van der Meer, H. J. Lamb, H. W.A.M. de Jong, M. Lubberink, J. A. Romijn, J. J. Bax, A. de Roos, J. W. Twisk, R. J. Heine, et al.
Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy: Studies With Cardiac Positron Emission Tomography and Magnetic Resonance Imaging
J. Am. Coll. Cardiol.,
October 13, 2009;
54(16):
1524 - 1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. van der Meer, L. J. Rijzewijk, H. W.A.M. de Jong, H. J. Lamb, M. Lubberink, J. A. Romijn, J. J. Bax, A. de Roos, O. Kamp, W. J. Paulus, et al.
Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus
Circulation,
April 21, 2009;
119(15):
2069 - 2077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hu, J. D. Klein, J. Du, and X. H. Wang
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Endocrinology,
November 1, 2008;
149(11):
5384 - 5390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Soto, P. Herrero, K. B. Schechtman, A. D. Waggoner, J. M. Baumstark, A. A. Ehsani, and R. J. Gropler
Exercise training impacts the myocardial metabolism of older individuals in a gender-specific manner
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H842 - H850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Peterson, P. Herrero, J. McGill, K. B. Schechtman, Z. Kisrieva-Ware, D. Lesniak, and R. J. Gropler
Fatty Acids and Insulin Modulate Myocardial Substrate Metabolism in Humans With Type 1 Diabetes
Diabetes,
January 1, 2008;
57(1):
32 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Herrero, C. S. Dence, A. R. Coggan, Z. Kisrieva-Ware, P. Eisenbeis, and R. J. Gropler
L-3-11C-Lactate as a PET Tracer of Myocardial Lactate Metabolism: A Feasibility Study
J. Nucl. Med.,
December 1, 2007;
48(12):
2046 - 2055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2009 - H2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Chandler, E. E. Morgan, T. A. McElfresh, T. A. Kung, J. H. Rennison, B. D. Hoit, and M. E. Young
Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1609 - H1616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley
Cardiac Energy Metabolism in Obesity
Circ. Res.,
August 17, 2007;
101(4):
335 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boudina and E. D. Abel
Diabetic Cardiomyopathy Revisited
Circulation,
June 26, 2007;
115(25):
3213 - 3223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman
Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass
Eur. Heart J.,
March 1, 2007;
28(5):
553 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boudina and E. D. Abel
Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.
Physiology,
August 1, 2006;
21:
250 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Welch, J. S. Lewis, J. Kim, T. L. Sharp, C. S. Dence, R. J. Gropler, and P. Herrero
Assessment of Myocardial Metabolism in Diabetic Rats Using Small-Animal PET: A Feasibility Study
J. Nucl. Med.,
April 1, 2006;
47(4):
689 - 697.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|